|
, M.D., and Stephan D. Gadola, M.D.
|
|||
| |||||||||||||||||||||||||||||||||||||||
According to the prevailing paradigm, major-histocompatibility-complex (MHC) class II–dependent CD4+
Source Information
From the Division of Infection, Inflammation and Repair, Southampton General Hospital, Southampton, United Kingdom.
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |